17 /100
LOW RISK
Score updated May 29, 2026

TCRX — TScan Therapeutics, Inc. Dilution Risk Tracker

Track TCRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TCRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.11 approaching $1 threshold
🔔 Track TCRX — Get forecast alerts →

💹 Market Data

Market Cap$70.58M
Shares Outstanding61.07M
Float55.39M
Cash$128.06M
Debt$92.54M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 11.4% shares (2025Q4 vs prior)
60 institutional holders · 31.02M shares
#1 Lynx1 Capital Management LP 8.02M shares
#2 BVF INC/IL 5.23M shares
#3 BAKER BROS. ADVISORS LP 2.78M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest870.2K
Days to Cover1.0
% of Float1.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
4 INSIDER TRANSACTION Jan 22, 2026
4 INSIDER TRANSACTION Jan 22, 2026
4 INSIDER TRANSACTION Jan 22, 2026
4 INSIDER TRANSACTION Jan 22, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TCRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TCRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TCRX
📊 TCRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TCRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.